Innovative Hemoperfusion Resin for Bilirubin Removal—— Empowering Safer, More Effective Blood Purification Therapies
Background: Addressing the Challenge of Hyperbilirubinemia
Bilirubin is a natural product of red blood cell metabolism. Under normal conditions, it functions as an antioxidant. However, when bilirubin accumulates due to liver dysfunction or impaired metabolism, it leads to hyperbilirubinemia, a condition that can cause jaundice and, in severe cases, damage vital organs such as the brain and kidneys.
Traditional drug-based treatments often show limited effectiveness and slow response times. In recent years, hemoperfusion technology—a process in which blood is circulated outside the body through an adsorption column—has emerged as a safe, efficient, and rapid therapy for removing toxins and metabolic waste from the bloodstream.
Limitations of Conventional Hemoperfusion Adsorbents
Commercially available adsorbents for bilirubin removal are primarily polystyrene–divinylbenzene anion exchange resins. While widely used, they still face major challenges:
- Disruption of ionic balance and unwanted adsorption of heparin during use;
- Low bilirubin adsorption capacity, limiting therapeutic efficiency;
- Poor biocompatibility, often requiring additional coating layers for clinical safety.
These shortcomings have hindered the broader adoption of hemoperfusion therapy in clinical settings.
Sunresin’s Solution: High-Selectivity, High-Compatibility Hemoperfusion Resin
Sunresin has developed an advanced blood purification resin specifically designed for bilirubin adsorption. The material integrates innovative polymer design, precise structural control, and superior biocompatibility—achieving major performance breakthroughs in safety and efficiency.
Key Advantages:
1.High Selectivity and Efficiency
By optimizing the crosslinking degree (≥80%) and ensuring a polyvinylpyrrolidone (PVP) content of ≥16%, the resin exhibits exceptional selectivity for bilirubin. It minimizes non-specific adsorption of serum proteins such as albumin, maintaining both purification performance and blood safety.
2.Enhanced Adsorption Capacity
With a large specific surface area and high functional group density, the resin’s bilirubin adsorption capacity is more than 3.6 times higher than conventional commercial products, significantly improving treatment speed and efficiency.
3.Superior Biocompatibility
The high hydrophilicity provided by PVP minimizes immune reactions and ensures excellent blood compatibility, making the resin suitable for direct blood contact applications in hemoperfusion systems.
Driving the Future of Blood Purification Materials
Sunresin’s innovation in hemoperfusion resin technology represents a major step forward in advanced biomedical materials. Beyond bilirubin removal, the technology provides a scalable and customizable platform for the purification of other toxins and metabolites in clinical applications such as:
- Liver failure and hepatic encephalopathy treatment
- Drug and poison detoxification
- Comprehensive blood purification therapies
By integrating material design, process engineering, and system development, Sunresin continues to advance the next generation of blood purification technologies—empowering healthcare innovation and improving patient outcomes.
Sunresin has collaborated with leading medical and biopharmaceutical companies globally to develop and commercialize advanced adsorption and separation solutions.
If you are interested in exploring clinical or industrial collaboration opportunities, please contact us—our specialists in blood purification materials will be glad to provide detailed case studies and technical support.
Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy ＆ Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment＆Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Mobile Sorption Module for Gold Extraction
PFAS Removal
Bio-Pharmaceutical & Life Science
Modern biopharmaceutical technologies typically use biological microbial fermentation...
Chemical Industry
Purification of chemical compounds has become a vital part of most industrial processes.
Drinking Water Treatment
Drinking water is essential to life. Every day every human being has to drink and use water for food preparation.
Food & Beverage Industries
Food is closely related to everyone, and the finishing of food comes from people's relentless pursuit...
Hydrometallurgy ＆ Mining
Hydrometallurgy is a technique for extractive metallugry involving the three general area...
Direct Lithium Extraction (DLE)
Sunresin is the major DLE lithium sorbent producer in China which mainly used for extraction lithium from salar brine and geothermal brine etc with high efficiency.
Industry Water Treatment
There are many uses of water in industry and, in most cases, the used water also needs treatment to render...
Plant Extraction
Plant Extraction is a process to gather the trace bioactive compounds from the tissue of a plant.
VOCs Treatment
With the widespread use of chemical products in the industry, more and more organic...
Wastewater Treatment
Wastewater treatment is the process of converting wastewater into an effluent that can be discharged
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
11
2025 04
SZSE Visits Sunresin – An ETF Constituent Company in the CSI 500 Index
On the morning of March 28, the Shenzhen Stock Exchange (SZSE), along with representatives from Harvest Fund and over 30 other participants, visited Sunresin— a constituent company of the CSI 500 Index — for a special research and engagement activity.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit